ACCOUNTS - Final Accounts


Caseware UK (AP4) 2023.0.135 2023.0.135 2023-09-302023-09-30false2022-10-01Growth trees11truetrueThe members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006. 03238249 2022-10-01 2023-09-30 03238249 2021-10-01 2022-09-30 03238249 2023-09-30 03238249 2022-09-30 03238249 c:Director1 2022-10-01 2023-09-30 03238249 d:PlantMachinery 2022-10-01 2023-09-30 03238249 d:PlantMachinery 2023-09-30 03238249 d:PlantMachinery 2022-09-30 03238249 d:PlantMachinery d:OwnedOrFreeholdAssets 2022-10-01 2023-09-30 03238249 d:OfficeEquipment 2022-10-01 2023-09-30 03238249 d:OfficeEquipment 2023-09-30 03238249 d:OfficeEquipment 2022-09-30 03238249 d:OfficeEquipment d:OwnedOrFreeholdAssets 2022-10-01 2023-09-30 03238249 d:OwnedOrFreeholdAssets 2022-10-01 2023-09-30 03238249 d:CurrentFinancialInstruments 2023-09-30 03238249 d:CurrentFinancialInstruments 2022-09-30 03238249 d:CurrentFinancialInstruments d:WithinOneYear 2023-09-30 03238249 d:CurrentFinancialInstruments d:WithinOneYear 2022-09-30 03238249 d:ShareCapital 2023-09-30 03238249 d:ShareCapital 2022-09-30 03238249 d:RetainedEarningsAccumulatedLosses 2023-09-30 03238249 d:RetainedEarningsAccumulatedLosses 2022-09-30 03238249 c:FRS102 2022-10-01 2023-09-30 03238249 c:AuditExempt-NoAccountantsReport 2022-10-01 2023-09-30 03238249 c:FullAccounts 2022-10-01 2023-09-30 03238249 c:PrivateLimitedCompanyLtd 2022-10-01 2023-09-30 iso4217:GBP xbrli:pure

Registered number: 03238249










GREENHILLS NURSERY LIMITED








UNAUDITED

FINANCIAL STATEMENTS

FOR THE YEAR ENDED 30 SEPTEMBER 2023

 
GREENHILLS NURSERY LIMITED
 

CONTENTS



Page
Balance Sheet
 
 
1 - 2
Notes to the Financial Statements
 
 
3 - 7

 
GREENHILLS NURSERY LIMITED
REGISTERED NUMBER:03238249

BALANCE SHEET
AS AT 30 SEPTEMBER 2023

2023
2022
Note
£
£

Fixed assets
  

Tangible assets
 4 
-
1,633

  
-
1,633

Current assets
  

Stocks
  
155,300
159,300

Debtors: amounts falling due within one year
 5 
3,471
28,845

Cash at bank and in hand
  
21,122
30,281

  
179,893
218,426

Creditors: amounts falling due within one year
 6 
(36,925)
(32,477)

Net current assets
  
 
 
142,968
 
 
185,949

Total assets less current liabilities
  
142,968
187,582

  

Net assets
  
142,968
187,582


Capital and reserves
  

Called up share capital 
  
275,100
275,100

Profit and loss account
  
(132,132)
(87,518)

  
142,968
187,582

Page 1

 
GREENHILLS NURSERY LIMITED
REGISTERED NUMBER:03238249
    
BALANCE SHEET (CONTINUED)
AS AT 30 SEPTEMBER 2023

The director considers that the Company is entitled to exemption from audit under section 477 of the Companies Act 2006 and members have not required the Company to obtain an audit for the year in question in accordance with section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The Company has opted not to file the profit and loss account in accordance with provisions applicable to companies subject to the small companies' regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf by: 




................................................
Mr J B (Koos) Kruijer
Director

Date: 12 April 2024

The notes on pages 3 to 7 form part of these financial statements.

Page 2

 
GREENHILLS NURSERY LIMITED
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 SEPTEMBER 2023

1.


General information

Greenhills Nursery Limited is a private company, limited by shares, domiciled in England and Wales, registration number 03238249. The registered office is 11 Merus Court, Meridian Business Park, Leicester, LE19 1RJ.

The principal activity of the Company continued to be that of the growth of trees.

2.Accounting policies

 
2.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with Section 1A of Financial Reporting Standard 102, the Financial Reporting Standard applicable in the UK and the Republic of Ireland and the Companies Act 2006.

The following principal accounting policies have been applied:

 
2.2

Going concern

The going concern of the Company has been considered by the director and he believes the Company will trade for at least 12 months after the balance sheet signing date. The Company will receive the necessary support from the director.

 
2.3

Foreign currency translation

Functional and presentation currency

The Company's functional and presentational currency is GBP.

Transactions and balances

Foreign currency transactions are translated into the functional currency using the spot exchange rates at the dates of the transactions.

At each period end foreign currency monetary items are translated using the closing rate. Non-monetary items measured at historical cost are translated using the exchange rate at the date of the transaction and non-monetary items measured at fair value are measured using the exchange rate when fair value was determined.

Foreign exchange gains and losses resulting from the settlement of transactions and from the translation at period-end exchange rates of monetary assets and liabilities denominated in foreign currencies are recognised in the Profit and Loss Account except when deferred in other comprehensive income as qualifying cash flow hedges.

Page 3

 
GREENHILLS NURSERY LIMITED
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 SEPTEMBER 2023

2.Accounting policies (continued)

 
2.4

Revenue

Revenue is recognised to the extent that it is probable that the economic benefits will flow to the Company and the revenue can be reliably measured. Revenue is measured as the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. The following criteria must also be met before revenue is recognised:

Sale of goods

Revenue from the sale of goods is recognised when all of the following conditions are satisfied:
the Company has transferred the significant risks and rewards of ownership to the buyer;
the Company retains neither continuing managerial involvement to the degree usually associated with ownership nor effective control over the goods sold;
the amount of revenue can be measured reliably;
it is probable that the Company will receive the consideration due under the transaction; and
the costs incurred or to be incurred in respect of the transaction can be measured reliably.

  

 
2.5

Tangible fixed assets

Tangible fixed assets under the cost model are stated at historical cost less accumulated depreciation and any accumulated impairment losses. Historical cost includes expenditure that is directly attributable to bringing the asset to the location and condition necessary for it to be capable of operating in the manner intended by management.

At each reporting date the Company assesses whether there is any indication of impairment. If such indication exists, the recoverable amount of the asset is determined which is the higher of its fair value less costs to sell and its value in use. An impairment loss is recognised where the carrying amount exceeds the recoverable amount.

The Company adds to the carrying amount of an item of fixed assets the cost of replacing part of such an item when that cost is incurred, if the replacement part is expected to provide incremental future benefits to the Company. The carrying amount of the replaced part is derecognised. Repairs and maintenance are charged to profit or loss during the period in which they are incurred.

Depreciation is charged so as to allocate the cost of assets less their residual value over their estimated useful lives, using the straight-line method.

Depreciation is provided on the following basis:

Plant and machinery
-
15% straight line per annum
Office equipment
-
33.33% straight line per annum

The assets' residual values, useful lives and depreciation methods are reviewed, and adjusted prospectively if appropriate, or if there is an indication of a significant change since the last reporting date.

Gains and losses on disposals are determined by comparing the proceeds with the carrying amount and are recognised in profit or loss.

Page 4

 
GREENHILLS NURSERY LIMITED
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 SEPTEMBER 2023

2.Accounting policies (continued)

 
2.6

Stocks

Stocks are stated at the lower of cost and net realisable value, being the estimated selling price less costs to complete and sell. Cost is based on the cost of purchase on a first in, first out basis. Work in progress and finished goods include labour and attributable overheads.

At each balance sheet date, stocks are assessed for impairment. If stock is impaired, the carrying amount is reduced to its selling price less costs to complete and sell. The impairment loss is recognised immediately in the Profit and Loss Account.

 
2.7

Debtors

Short-term debtors are measured at transaction price, less any impairment. Loans receivable are measured initially at transacion price, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method, less any impairment.

 
2.8

Cash and cash equivalents

Cash is represented by cash in hand and deposits with financial institutions repayable without penalty on notice. Cash equivalents are highly liquid investments that mature in no more than three months from the date of acquisition and that are readily convertible to known amounts of cash with insignificant risk of change in value.

 
2.9

Creditors

Short-term creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at transaction price, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.

Page 5

 
GREENHILLS NURSERY LIMITED
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 SEPTEMBER 2023

2.Accounting policies (continued)

  
2.10

Financial instruments

The Company only enters into basic financial instrument transactions that result in the recognition of financial assets and liabilities like trade and other debtors and creditors, loans from banks and other third parties, loans to related parties and investments in non-puttable ordinary shares.
Debt instruments (other than those wholly repayable or receivable within one year), including loans and other accounts receivable and payable, are initially measured at transaction price, net of transaction costs, and subsequently at amortised cost using the effective interest method. Debt instruments that are payable or receivable within one year, typically trade debtors and creditors, are measured, initially and subsequently, at the undiscounted amount of the cash or other consideration expected to be paid or received. However, if the arrangements of a short-term instrument constitute a financing transaction, like the payment of a trade debt deferred beyond normal business terms or financed at a rate of interest that is not a market rate or in the case of an out-right short-term loan not at market rate, the financial asset or liability is measured, initially, at the present value of the future cash flow discounted at a market rate of interest for a similar debt instrument and subsequently at amortised cost.
Financial assets that are measured at cost and amortised cost are assessed at the end of each reporting period for objective evidence of impairment. If objective evidence of impairment is found, an impairment loss is recognised in the Profit and Loss Account.
For financial assets measured at amortised cost, the impairment loss is measured as the difference between an asset's carrying amount and the present value of estimated cash flows discounted at the asset's original effective interest rate. If a financial asset has a variable interest rate, the discount rate for measuring any impairment loss is the current effective interest rate determined under the contract.
For financial assets measured at cost less impairment, the impairment loss is measured as the difference between an asset's carrying amount and best estimate of the recoverable amount, which is an approximation of the amount that the Company would receive for the asset if it were to be sold at the balance sheet date.
Financial assets and liabilities are offset and the net amount reported in the Balance Sheet when there is an enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.


3.


Employees

The average monthly number of employees, including the director, during the year was 1 (2022 - 1).

Page 6

 
GREENHILLS NURSERY LIMITED
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 SEPTEMBER 2023

4.


Tangible fixed assets





Plant and machinery
Office equipment
Total

£
£
£



Cost or valuation


At 1 October 2022
3,536
6,667
10,203



At 30 September 2023

3,536
6,667
10,203



Depreciation


At 1 October 2022
3,536
5,034
8,570


Charge for the year on owned assets
-
1,633
1,633



At 30 September 2023

3,536
6,667
10,203



Net book value



At 30 September 2023
-
-
-



At 30 September 2022
-
1,633
1,633


5.


Debtors

2023
2022
£
£


Trade debtors
2,871
28,264

Prepayments and accrued income
600
581

3,471
28,845



6.


Creditors: Amounts falling due within one year

2023
2022
£
£

Trade creditors
26,513
22,024

Other taxation and social security
4,243
5,241

Accruals and deferred income
6,169
5,212

36,925
32,477


 
Page 7